Alnylam Pharmaceuticals
ALNY
#620
Rank
HK$254.59 B
Marketcap
HK$1,967
Share price
4.69%
Change (1 day)
70.56%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company